Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma
Mt. Hopfenspirger et al., Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma, INT IMMUNO, 1(9-10), 2001, pp. 1743-1751
Allergens, in combination with genetic predisposition, drive undifferentiat
ed T cells towards the type 2 T cells. Some childhood infections may activa
te the production of a type I T cell profile. It is reasonable to speculate
that a decrease in childhood infections may increase the incidence of alle
rgy by allowing the immune balance to shift towards the type 2 T cells. We
hypothesized that pre-exposure of mycobacterial antigens in sensitized mice
would prevent the development of asthma-like conditions. Specifically. we
examined the effect of mycobacterial antigens, Bacillus Calmette-Guerin (BC
G) vaccine and Mycobacterium vaccae, on antigen-induced bronchoconstriction
, airway hyperresponsiveness to methacholine, bronchoalveolar lavage eosino
philia, and plasma IL-4 and IL-12 levels in ovalbumin (OVA)-sensitized and
challenged Balb/c mice. Challenge with OVA produced a 2-3-fold increase in
bronchoconstriction within 3-5 min, followed by a delayed response after 60
min, the latter of which was significantly attenuated by both BCG and M. v
accae. Airway hyperresponsiveness to methacholine 24 h after OVA challenge
was prevented by BCG and M. vaccae. Airway eosinophilia was also prevented
by BCG and M. vaccae. The plasma IL-12 levels were significantly increased
and plasma IL-4 levels were significantly decreased following BCG or M. vac
cae administration in OVA-sensitized and challenged mice. Interestingly, a
significant increase in plasma IL-12 was observed with BCG as compared to M
. vaccae administration, suggesting a stronger type I response to BCG. Thes
e data support our hypothesis and suggest that BCG and M. vaccae may preven
t the underlying pathophysiological changes in asthma. (C) 2001 Elsevier Sc
ience B.V. All rights reserved.